Nicola J Armstrong1, Karen A Mather2,3, Muralidharan Sargurupremraj4, Maria J Knol5, Rainer Malik6, Claudia L Satizabal7,8,9, Lisa R Yanek10, Wei Wen2, Vilmundur G Gudnason11,12, Nicole D Dueker13, Lloyd T Elliott14,15, Edith Hofer16,17, Joshua Bis18, Neda Jahanshad19, Shuo Li20, Mark A Logue21,20,22, Michelle Luciano23, Markus Scholz24, Albert V Smith12, Stella Trompet25,26, Dina Vojinovic5, Rui Xia27, Fidel Alfaro-Almagro15, David Ames28,29, Najaf Amin5, Philippe Amouyel30,31, Alexa S Beiser8,9,20, Henry Brodaty2,32, Ian J Deary23, Christine Fennema-Notestine33,34, Piyush G Gampawar35, Rebecca Gottesman36, Ludovica Griffanti15, Clifford R Jack37, Mark Jenkinson15, Jiyang Jiang2, Brian G Kral10, John B Kwok38,39, Leonie Lampe40, David C M Liewald23, Pauline Maillard41, Jonathan Marchini42, Mark E Bastin23,43, Bernard Mazoyer44, Lukas Pirpamer45, José Rafael Romero8,9, Gennady V Roshchupkin5,46, Peter R Schofield38,3, Matthias L Schroeter47,48,49, David J Stott50, Anbupalam Thalamuthu2,3, Julian Trollor2,51, Christophe Tzourio4,52, Jeroen van der Grond53, Meike W Vernooij5,46, Veronica A Witte54,40, Margaret J Wright55,56, Qiong Yang20, Zoe Morris57, Siggi Siggurdsson7,8,9, Bruce Psaty18, Arno Villringer48,49, Helena Schmidt35, Asta K Haberg58,59, Cornelia M van Duijn5,60, J Wouter Jukema61,62, Martin Dichgans6,63,64, Ralph L Sacco65,66,67, Clinton B Wright68, William S Kremen69,70, Lewis C Becker10, Paul M Thompson19, Thomas H Mosley71, Joanna M Wardlaw23,43, M Arfan Ikram5, Hieab H H Adams5,46,72, Sudha Seshadri11, Perminder S Sachdev2,73, Stephen M Smith15, Lenore Launer74, William Longstreth18, Charles DeCarli75, Reinhold Schmidt16, Myriam Fornage27,76, Stephanie Debette4,77, Paul A Nyquist10,78,79. 1. Mathematics and Statistics, Murdoch University, Perth, Australia (N.J.A.). 2. Centre for Healthy Brain Ageing, School of Psychiatry (K.A.M., W.W., H.B., J.J., A.T., J.T., P.S.S.), University of New South Wales, Sydney, Australia. 3. Neuroscience Research Australia, Sydney, Australia (K.A.M., P.R.S., A.T.). 4. University Bordeaux, Inserm, Bordeaux Population Health Research Center, France (M.S., C.T., S.D.). 5. Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands (M.J.K., D.V., N.A., G.V.R., M.W.V., C.M.v.D., M.A.I., H.H.H.A.). 6. Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-Universität LMU Munich, Germany (R.M., M.D.). 7. Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, UT Health San Antonio, San Antonio, TX (C.L.S., S.S.). 8. The Framingham Heart Study, MA (C.L.S., A.S.B., J.R.R., S.S.). 9. Department of Neurology (C.L.S., A.S.B., J.R.R., S.S.), Boston University School of Medicine, MA. 10. GeneSTAR Research Program (L.R.Y., B.G.K., L.C.B., P.A.N.), Johns Hopkins University School of Medicine, Baltimore, MD. 11. Icelandic Heart Association, Kopavogur (V.G.G., S.S.). 12. University of Iceland, Reykjavik, Iceland (V.G.G., A.V.S.). 13. Dr. John T. Macdonald Foundation Department of Human Genetics (R.L.S.), University of Miami, FL. 14. Department of Statistics and Actuarial Science, Simon Fraser University, Burnaby, BC, Canada (L.T.E.). 15. Wellcome Centre for Integrative Neuroimaging (WIN FMRIB) (L.T.E., F.A.-A., L.G., M.J., S.M.S.), University of Oxford, United Kingdom. 16. Clinical Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Austria (E.H., R.S.). 17. Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Austria (E.H.). 18. Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA (J.B., B.P., W.L.). 19. Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Marina del Rey (N.J., P.M.T.). 20. Department of Biostatistics, Boston University School of Public Health, Boston, MA (S.L., M.A.L., A.S.B., Q.Y.). 21. Department of Psychiatry and Biomedical Genetics Section (M.A.L.), Boston University School of Medicine, MA. 22. National Center for PTSD: Behavioral Science Division, VA Boston Healthcare System, Boston, MA (M.A.L.). 23. Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, United Kingdom (M.L., I.J.D., D.C.M.L., M.E.B., J.M.W.). 24. Institute for Medical Informatics, Statistics and Epidemiology (M.S.). 25. Department of Internal Medicine, Section of Gerontology and Geriatrics (S.T.), Leiden University Medical Center, the Netherlands. 26. Department of Cardiology (S.T.), Leiden University Medical Center, the Netherlands. 27. Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, TX (R.X., M.F.). 28. National Ageing Research Institute, Parkville, Victoria, Australia (D.A.). 29. Academic Unit for Psychiatry of Old Age, University of Melbourne, St George's Hospital, Kew, Australia (D.A.). 30. Lille University, Inserm, Institut Pasteur de Lille, RID-AGE - Risk Factors and Molecular Determinants of Aging-Related Diseases and Labex Distalz, France (P.A.). 31. Lille University, Inserm, CHU Lille, Institut Pasteur de Lille, RID-AGE (P.A.). 32. Dementia Centre for Research Collaboration (H.B.), University of New South Wales, Sydney, Australia. 33. Department of Psychiatry (C.F.-N.), University of California, San Diego, La Jolla, CA. 34. Center for Behavior Genetics of Aging (C.F.-N.), University of California, San Diego, La Jolla, CA. 35. Gottfried Schatz Research Center (for Cell Signaling, Metabolism and Aging), Medical University of Graz, Austria (P.G.G., H.S.). 36. Department of Neurology, Cerebrovascular and stroke Division (R.G.), Johns Hopkins University School of Medicine, Baltimore, MD. 37. Department of Radiology, Mayo Clinic, Rochester, MN (C.R.J.J.). 38. School of Medical Sciences (J.B.K., P.R.S.), University of New South Wales, Sydney, Australia. 39. Brain and Mind Centre - The University of Sydney, Camperdown, NSW, Australia (J.B.K.). 40. Department of Neurology, Max-Planck-Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (L.L., V.A.W.). 41. Imaging of Dementia and Aging (IDeA) Laboratory, Department of Neurology, University of California-Davis, Davis, CA (P.M.). 42. Statistical Genetics and Methods at Regeneron Pharmaceuticals, Inc, New York, NY (J.M.). 43. Centre for Clinical Brain Sciences, Edinburgh Imaging, Centre for Cognitive Ageing, University of Edinburgh, United Kingdom (M.E.B., J.M.W.). 44. Institut des Maladies Neurodégénératives, University of Bordeaux, France (B.M.). 45. Clinical Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Austria (L.P.). 46. Department of Radiology and Nuclear Medicine (G.V.R., M.W.V., H.H.H.A.). 47. LIFE Research Center for Civilization Disease, Leipzig, Germany (M.S.). 48. Department of Neurology, Max-Planck-Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (M.L.S., A.V.). 49. Day Clinic for Cognitive Neurology, University Hospital Leipzig, Germany (M.L.S., A.V.). 50. Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom (D.J.S.). 51. Department of Developmental Disability Neuropsychiatry, School of Psychiatry (J.T.), University of New South Wales, Sydney, Australia. 52. CHU de Bordeaux, Public Health Department, Medical information Department, Bordeaux, France (C.T.). 53. Department of Radiology (J.v.d.G.), Leiden University Medical Center, the Netherlands. 54. Collaborative Research Center 1052 Obesity Mechanisms, Faculty of Medicine, University of Leipzig, Germany (V.A.W). 55. Queensland Brain Institute (M.J.W.), The University of Queensland, St Lucia, QLD, Australia. 56. Centre for Advanced Imaging (M.J.W.), The University of Queensland, St Lucia, QLD, Australia. 57. Neuroradiology Department, Department of Clinical Neurosciences, Western General Hospital, Edinburgh, United Kingdom (Z.M.). 58. Department of Neuromedicine and Movement Science (A.K.H.), Norwegian University of Science and Technology, Trondheim, Norway. 59. Department of Radiology and Nuclear Medicine (A.K.H.), Norwegian University of Science and Technology, Trondheim, Norway. 60. Nuffield Department of Population Health (C.M.v.D.), University of Oxford, United Kingdom. 61. Department of Cardiology (J.W.J.), Leiden University Medical Center, the Netherlands. 62. Einthoven Laboratory for Experimental Vascular Medicine, LUMC, Leiden, the Netherlands (J.W.J.). 63. German Center for Neurodegenerative Diseases, Munich, Germany (M.D.). 64. Munich Cluster for Systems Neurology (SyNergy), Germany (M.D.). 65. Department of Public Health Sciences, Miller School of Medicine (R.L.S.), University of Miami, FL. 66. Department of Neurology, Miller School of Medicine (R.L.S.), University of Miami, FL. 67. Evelyn F. McKnight Brain Institute, Department of Neurology (R.L.S.), University of Miami, FL. 68. National Institute of Neurological Disorders and Stroke (C.B.W.), National Institutes of Health, Bethesda, MD. 69. Center for Behavior Genetics of Aging (W.S.K.), University of California, San Diego, La Jolla, CA. 70. Department of Psychiatry (W.S.K.), University of California, San Diego, La Jolla, CA. 71. Department of Geriatric Medicine, Memory Impairment and Neurodegenerative Dementia (MIND) Center, University of Mississippi Medical Center, Jackson (T.H.M.). 72. Department of Clinical Genetics, Erasmus MC, Rotterdam, the Netherlands (H.H.H.A.). 73. Neuropsychiatric Institute, Prince of Wales Hospital, Sydney, Australia (P.S.S.). 74. Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Intramural Research Program (L.L.), National Institutes of Health, Bethesda, MD. 75. Alzheimer's Disease Center and Imaging of Dementia and Aging (IDeA) Laboratory, Department of Neurology and Center for Neuroscience University of California at Davis (C.D.). 76. Human Genetics Center, School of Public Health UT, Houston, TX (M.F.). 77. Department of Neurology, CHU de Bordeaux (University Hospital), Bordeaux, France (S.D.). 78. Departments of Neurology, Critical Care Medicine, Neurosurgery (P.A.N.), Johns Hopkins University School of Medicine, Baltimore, MD. 79. Critical Care Medicine Department (P.A.N.), National Institutes of Health, Bethesda, MD.
Abstract
BACKGROUND AND PURPOSE: Periventricular white matter hyperintensities (WMH; PVWMH) and deep WMH (DWMH) are regional classifications of WMH and reflect proposed differences in cause. In the first study, to date, we undertook genome-wide association analyses of DWMH and PVWMH to show that these phenotypes have different genetic underpinnings. METHODS: Participants were aged 45 years and older, free of stroke and dementia. We conducted genome-wide association analyses of PVWMH and DWMH in 26,654 participants from CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology), ENIGMA (Enhancing Neuro-Imaging Genetics Through Meta-Analysis), and the UKB (UK Biobank). Regional correlations were investigated using the genome-wide association analyses -pairwise method. Cross-trait genetic correlations between PVWMH, DWMH, stroke, and dementia were estimated using LDSC. RESULTS: In the discovery and replication analysis, for PVWMH only, we found associations on chromosomes 2 (NBEAL), 10q23.1 (TSPAN14/FAM231A), and 10q24.33 (SH3PXD2A). In the much larger combined meta-analysis of all cohorts, we identified ten significant regions for PVWMH: chromosomes 2 (3 regions), 6, 7, 10 (2 regions), 13, 16, and 17q23.1. New loci of interest include 7q36.1 (NOS3) and 16q24.2. In both the discovery/replication and combined analysis, we found genome-wide significant associations for the 17q25.1 locus for both DWMH and PVWMH. Using gene-based association analysis, 19 genes across all regions were identified for PVWMH only, including the new genes: CALCRL (2q32.1), KLHL24 (3q27.1), VCAN (5q27.1), and POLR2F (22q13.1). Thirteen genes in the 17q25.1 locus were significant for both phenotypes. More extensive genetic correlations were observed for PVWMH with small vessel ischemic stroke. There were no associations with dementia for either phenotype. CONCLUSIONS: Our study confirms these phenotypes have distinct and also shared genetic architectures. Genetic analyses indicated PVWMH was more associated with ischemic stroke whilst DWMH loci were implicated in vascular, astrocyte, and neuronal function. Our study confirms these phenotypes are distinct neuroimaging classifications and identifies new candidate genes associated with PVWMH only.
BACKGROUND AND PURPOSE: Periventricular white matter hyperintensities (WMH; PVWMH) and deep WMH (DWMH) are regional classifications of WMH and reflect proposed differences in cause. In the first study, to date, we undertook genome-wide association analyses of DWMH and PVWMH to show that these phenotypes have different genetic underpinnings. METHODS: Participants were aged 45 years and older, free of stroke and dementia. We conducted genome-wide association analyses of PVWMH and DWMH in 26,654 participants from CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology), ENIGMA (Enhancing Neuro-Imaging Genetics Through Meta-Analysis), and the UKB (UK Biobank). Regional correlations were investigated using the genome-wide association analyses -pairwise method. Cross-trait genetic correlations between PVWMH, DWMH, stroke, and dementia were estimated using LDSC. RESULTS: In the discovery and replication analysis, for PVWMH only, we found associations on chromosomes 2 (NBEAL), 10q23.1 (TSPAN14/FAM231A), and 10q24.33 (SH3PXD2A). In the much larger combined meta-analysis of all cohorts, we identified ten significant regions for PVWMH: chromosomes 2 (3 regions), 6, 7, 10 (2 regions), 13, 16, and 17q23.1. New loci of interest include 7q36.1 (NOS3) and 16q24.2. In both the discovery/replication and combined analysis, we found genome-wide significant associations for the 17q25.1 locus for both DWMH and PVWMH. Using gene-based association analysis, 19 genes across all regions were identified for PVWMH only, including the new genes: CALCRL (2q32.1), KLHL24 (3q27.1), VCAN (5q27.1), and POLR2F (22q13.1). Thirteen genes in the 17q25.1 locus were significant for both phenotypes. More extensive genetic correlations were observed for PVWMH with small vessel ischemic stroke. There were no associations with dementia for either phenotype. CONCLUSIONS: Our study confirms these phenotypes have distinct and also shared genetic architectures. Genetic analyses indicated PVWMH was more associated with ischemic stroke whilst DWMH loci were implicated in vascular, astrocyte, and neuronal function. Our study confirms these phenotypes are distinct neuroimaging classifications and identifies new candidate genes associated with PVWMH only.
Entities:
Keywords:
brain; genome-wide association study; neuroimaging; risk factors; white matter
Authors: Brendan K Bulik-Sullivan; Po-Ru Loh; Hilary K Finucane; Stephan Ripke; Jian Yang; Nick Patterson; Mark J Daly; Alkes L Price; Benjamin M Neale Journal: Nat Genet Date: 2015-02-02 Impact factor: 38.330
Authors: Myriam Fornage; Stephanie Debette; Joshua C Bis; Helena Schmidt; M Arfan Ikram; Carole Dufouil; Sigurdur Sigurdsson; Thomas Lumley; Anita L DeStefano; Franz Fazekas; Henri A Vrooman; Dean K Shibata; Pauline Maillard; Alex Zijdenbos; Albert V Smith; Haukur Gudnason; Renske de Boer; Mary Cushman; Bernard Mazoyer; Gerardo Heiss; Meike W Vernooij; Christian Enzinger; Nicole L Glazer; Alexa Beiser; David S Knopman; Margherita Cavalieri; Wiro J Niessen; Tamara B Harris; Katja Petrovic; Oscar L Lopez; Rhoda Au; Jean-Charles Lambert; Albert Hofman; Rebecca F Gottesman; Melissa Garcia; Susan R Heckbert; Larry D Atwood; Diane J Catellier; Andre G Uitterlinden; Qiong Yang; Nicholas L Smith; Thor Aspelund; Jose R Romero; Kenneth Rice; Kent D Taylor; Michael A Nalls; Jerome I Rotter; Richey Sharrett; Cornelia M van Duijn; Philippe Amouyel; Philip A Wolf; Vilmundur Gudnason; Aad van der Lugt; Eric Boerwinkle; Bruce M Psaty; Sudha Seshadri; Christophe Tzourio; Monique M B Breteler; Thomas H Mosley; Reinhold Schmidt; W T Longstreth; Charles DeCarli; Lenore J Launer Journal: Ann Neurol Date: 2011-06 Impact factor: 10.422
Authors: Elly Verbeek; Marije E C Meuwissen; Frans W Verheijen; Paul P Govaert; Daniel J Licht; Debbie S Kuo; Cathryn J Poulton; Rachel Schot; Maarten H Lequin; Jeroen Dudink; Dicky J Halley; René I F de Coo; Jan C den Hollander; Renske Oegema; Douglas B Gould; Grazia M S Mancini Journal: Eur J Hum Genet Date: 2012-02-15 Impact factor: 4.246
Authors: Kristiina Rannikmäe; Gail Davies; Pippa A Thomson; Steve Bevan; William J Devan; Guido J Falcone; Matthew Traylor; Christopher D Anderson; Thomas W K Battey; Farid Radmanesh; Ranjan Deka; Jessica G Woo; Lisa J Martin; Jordi Jimenez-Conde; Magdy Selim; Devin L Brown; Scott L Silliman; Chelsea S Kidwell; Joan Montaner; Carl D Langefeld; Agnieszka Slowik; Björn M Hansen; Arne G Lindgren; James F Meschia; Myriam Fornage; Joshua C Bis; Stéphanie Debette; Mohammad A Ikram; Will T Longstreth; Reinhold Schmidt; Cathy R Zhang; Qiong Yang; Pankaj Sharma; Steven J Kittner; Braxton D Mitchell; Elizabeth G Holliday; Christopher R Levi; John Attia; Peter M Rothwell; Deborah L Poole; Giorgio B Boncoraglio; Bruce M Psaty; Rainer Malik; Natalia Rost; Bradford B Worrall; Martin Dichgans; Tom Van Agtmael; Daniel Woo; Hugh S Markus; Sudha Seshadri; Jonathan Rosand; Cathie L M Sudlow Journal: Neurology Date: 2015-02-04 Impact factor: 9.910
Authors: Matthew Traylor; Rainer Malik; Mike A Nalls; Ioana Cotlarciuc; Farid Radmanesh; Gudmar Thorleifsson; Ken B Hanscombe; Carl Langefeld; Danish Saleheen; Natalia S Rost; Idil Yet; Tim D Spector; Jordana T Bell; Eilis Hannon; Jonathan Mill; Ganesh Chauhan; Stephanie Debette; Joshua C Bis; W T Longstreth; M Arfan Ikram; Lenore J Launer; Sudha Seshadri; Monica Anne Hamilton-Bruce; Jordi Jimenez-Conde; John W Cole; Reinhold Schmidt; Agnieszka Słowik; Robin Lemmens; Arne Lindgren; Olle Melander; Raji P Grewal; Ralph L Sacco; Tatjana Rundek; Kathryn Rexrode; Donna K Arnett; Julie A Johnson; Oscar R Benavente; Sylvia Wasssertheil-Smoller; Jin-Moo Lee; Sara L Pulit; Quenna Wong; Stephen S Rich; Paul I W de Bakker; Patrick F McArdle; Daniel Woo; Christopher D Anderson; Huichun Xu; Laura Heitsch; Myriam Fornage; Christina Jern; Kari Stefansson; Unnur Thorsteinsdottir; Solveig Gretarsdottir; Cathryn M Lewis; Pankaj Sharma; Cathie L M Sudlow; Peter M Rothwell; Giorgio B Boncoraglio; Vincent Thijs; Chris Levi; James F Meschia; Jonathan Rosand; Steven J Kittner; Braxton D Mitchell; Martin Dichgans; Bradford B Worrall; Hugh S Markus Journal: Ann Neurol Date: 2017-03 Impact factor: 10.422
Authors: Joseph K Pickrell; Tomaz Berisa; Jimmy Z Liu; Laure Ségurel; Joyce Y Tung; David A Hinds Journal: Nat Genet Date: 2016-05-16 Impact factor: 38.330
Authors: Rainer Malik; Kristiina Rannikmäe; Matthew Traylor; Marios K Georgakis; Muralidharan Sargurupremraj; Hugh S Markus; Jemma C Hopewell; Stephanie Debette; Cathie L M Sudlow; Martin Dichgans Journal: Ann Neurol Date: 2018-11-30 Impact factor: 10.422
Authors: Rainer Malik; Nathalie Beaufort; Simon Frerich; Benno Gesierich; Marios K Georgakis; Kristiina Rannikmäe; Amy C Ferguson; Christof Haffner; Matthew Traylor; Michael Ehrmann; Cathie L M Sudlow; Martin Dichgans Journal: Brain Date: 2021-10-22 Impact factor: 15.255
Authors: Mark Sanderson-Cimino; Matthew S Panizzon; Jeremy A Elman; Xin Tu; Daniel E Gustavson; Olivia Puckett; Karalani Cross; Randy Notestine; Sean N Hatton; Lisa T Eyler; Linda K McEvoy; Donald J Hagler; Michael C Neale; Nathan A Gillespie; Michael J Lyons; Carol E Franz; Christine Fennema-Notestine; William S Kremen Journal: Neuropsychology Date: 2021-03 Impact factor: 3.295
Authors: Michelle C Johansen; Rebecca F Gottesman; Brian G Kral; Dhananjay Vaidya; Lisa R Yanek; Lewis C Becker; Diane M Becker; Paul Nyquist Journal: Stroke Date: 2021-05-18 Impact factor: 10.170
Authors: Keun-Hwa Jung; Kimberly A Stephens; Kathryn M Yochim; Joost M Riphagen; Chan Mi Kim; Randy L Buckner; David H Salat Journal: Stroke Date: 2021-01-07 Impact factor: 10.170
Authors: Brittney L Blevins; Harry V Vinters; Seth Love; Donna M Wilcock; Lea T Grinberg; Julie A Schneider; Rajesh N Kalaria; Yuriko Katsumata; Brian T Gold; Danny J J Wang; Samantha J Ma; Lincoln M P Shade; David W Fardo; Anika M S Hartz; Gregory A Jicha; Karin B Nelson; Shino D Magaki; Frederick A Schmitt; Merilee A Teylan; Eseosa T Ighodaro; Panhavuth Phe; Erin L Abner; Matthew D Cykowski; Linda J Van Eldik; Peter T Nelson Journal: Acta Neuropathol Date: 2020-10-24 Impact factor: 17.088
Authors: Antoine Garnier-Crussard; Salma Bougacha; Miranka Wirth; Sophie Dautricourt; Siya Sherif; Brigitte Landeau; Julie Gonneaud; Robin De Flores; Vincent de la Sayette; Denis Vivien; Pierre Krolak-Salmon; Gaël Chételat Journal: Alzheimers Dement Date: 2021-07-28 Impact factor: 16.655